http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021203704-A9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d84aa8c4818bda002eded1de6d318389
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2020-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9387516d82da4b2cc773c9fe8c7e3f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb8e4041ab2b2784e43ccf7bd843537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_362f182a7c23199c122615ed3c31395d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9612890b320a8ba20c121bc2182722d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76b311735f1236c9506e5bf1a86eace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8d305d325676a8f3ca3bf85c026bb37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a19c55a80c702a62cec92a3ccc91df1
publicationDate 2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021203704-A9
titleOfInvention Use of bacitracin a in preparation of drugs for preventing and treating coronaviruses
abstract Provided by the present invention is the use of bacitracin A in the preparation of drugs for preventing and treating coronaviruses. Specifically, disclosed is the use of bacitracin A or pharmaceutically acceptable salts, isotopes, stereoisomers, mixtures of stereoisomers, tautomers, esters, amides, or prodrugs thereof in the preparation of drugs for preventing and/or treating diseases caused by coronaviruses. The coronaviruses are the novel coronaviruses SARS-CoV-2, SARS-CoV, HCoV 229E, NL63, OC43, HKU1, and MERS-CoV.
priorityDate 2020-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227307598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439542

Total number of triples: 29.